Board of Directors
Ash Kaushal, BSc
Director, President & CEO
Mr. Kaushal has over 25 years of experience in product development in the medical, defence, safety and nuclear industries. Mr. Kaushal has held Vice President and senior level management positions with several Canadian and British corporations throughout his career including NIR Science Corp and NIR Diagnostics Corp in Campbellvile, Ontario, CME Telemetrix in Waterloo, Indal Technologies in Mississauga, Ontario and several companies based in England, UK. Mr. Kaushal has developed handheld products from initial concept right through to FDA submission. In these positions he had responsibility for research, engineering, quality assurance and clinical trials.
James Samsoondar, Ph.D., FCACB
Director & Chief Science Officer
James Samsoondar holds a Ph.D. in Clinical Biochemistry from the University of Toronto. He is a Certified Clinical Biochemist and a Fellow of the Canadian Academy of Clinical Biochemistry (FCACB). He is currently Chair of the Professional Affairs Committee of the Ontario Society of Clinical Chemists and sits on the Chemistry Committee of the Institute of Quality Management in Healthcare. He is also Clinical Biochemist, Quality Manager and Chair of the Point-of-Care Testing (POCT) Advisory Committee at The Scarborough Hospital (affiliated with the University of Toronto).
James has been awarded 37 patents to date. He developed and licensed technology to Johnson & Johnson which is incorporated into the company’s Central Laboratory Chemistry Analyzer–the most popular lab analyzer in Ontario. He developed the HemoNIR hand-held analyzer with a previous company and went on to found ChroMedX in 2005.
Michael Minder is a seasoned finance professional with over 15 years of international banking experience. He held senior leadership roles in Asset and Wealth Management for Credit Suisse Group in both Switzerland and North America, managing assets of high net worth accounts.
In 1998 he left the Credit Suisse Group to form his own firm providing international investment banking and investor relations advisory services to numerous U.S., Canadian, and European listed companies. Michael is the current CFO of TSX Venture listed Zecotek Photonics Inc. a Company focused on the innovation and commercialization of key enabling technology, subsystems, and components for medical and industrial imaging.
George Langdon, Ph.D.,
George Langdon studied geology at the Memorial University of Newfoundland, where he took BSc., MSc and PhD degrees between 1978 and 1996. He joined the petroleum industry as an exploration geologist in 1980, and worked for majors Hudson’s Bay Oil and Gas in Calgary, Saudi ARAMCO in Dhahran, Saudi Arabia, and Mobil Oil Canada in Toronto, until 1999. Since that time he has acted as a consultant for, and has been involved in the development of junior public companies in the oil and gas sector, especially in eastern Canada, including Canadian Imperial Venture Corp. (TSXV-CQV) in western Newfoundland, and Contact Exploration Inc. in New Brunswick. In 2006 he became the founding President of Shoal Point Energy Ltd. (CNSX-SHP) where he served until June 2013. Dr. Langdon was co-responsible as President and lead geologist for the company’s amassing a land position of some 720,000 acres in which it owns a 100% interest, and for negotiating a joint venture which aims to see up to 10 wells drilled over the next 3 to 4 years to assess this massive play, which has the potential to impact the energy balance in eastern North America over the next several years.
George also received a Bachelor of Fine Arts in Music Composition from York University, Toronto, in 1990, and continues a serious interest in music.
Gerard Edwards, B.Comm., MBA
Mr. Edwards has a background in finance and administration and was Co-founder and past President of Imperial Venture Corp./Canadian Imperial Venture Corp., as well as a co-founder and past president of Guigne Technologies Ltd., a St. John’s based high-tech company.